CMA sends third SO in hydrocortisone probe
The UK’s Competition and Markets Authority has provisionally found that drugmakers Auden McKenzie and Waymade artificially inflated prices of a life-saving drug through a pay-for-delay scheme.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.